Vertex Pharmaceuticals Stock Forecast

Sell candidate since Jun 02, 2026 Gain 0.76%

The Vertex Pharmaceuticals Incorporated stock price gained 0.765% on the last trading day (Wednesday, 3rd Jun 2026), rising from $425.09 to $428.34. During the last trading day the stock fluctuated 2.14% from a day low at $420.01 to a day high of $429.01. The price has risen in 6 of the last 10 days but is still down by -1.37% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 178 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $567.26 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.34% during the next 3 months and, with a 90% probability hold a price between $379.18 and $430.59 at the end of this 3-month period.

VRTX Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, April 29, 2026, and so far it has risen 1.20%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Vertex Pharmaceuticals Incorporated stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $437.21 and $434.82. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Vertex Pharmaceuticals Incorporated stock

Vertex Pharmaceuticals Incorporated finds support from accumulated volume at $427.65 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $9.00 (2.14%) between high and low. For the last week, the stock has had daily average volatility of 2.38%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VRTX) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Vertex Pharmaceuticals Incorporated to open at $425.79, and during the day (based on 14 day Average True Range), to move between $422.95 and $433.73, which gives a possible trading interval of +/-$10.78 (+/-2.55%) up or down from last closing price. If Vertex Pharmaceuticals Incorporated takes out the full calculated possible swing range there will be an estimated 2.55% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $427.65 (0.16%) than the resistance at $433.07 (1.10%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Vertex Pharmaceuticals Incorporated stock A Buy?

Vertex Pharmaceuticals Incorporated holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.889 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $425.79 ( 0.596%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk